Conference
A phase I, dose-escalation trial of continuous and pulsed-dose afatinib (A) combined with pemetrexed (P) in patients (pts) with advanced solid tumors: Final analysis.
Abstract
2523
Authors
Chu QS; Sangha RS; Hotte SJ; Sergenson G; Chand VK; Sufan R; Gu Y; Schnell D; Hirte HW
Volume
31
Pagination
pp. 2523-2523
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2013
DOI
10.1200/jco.2013.31.15_suppl.2523
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X